Government to take advantage of EU simplified drug registration law

"We need this change as it will be easier to adjust the documentation of Polish drugs to EU standards," said Mariusz Lewandowski, the spokesman of the association of domestic pharmaceutical companies, Polfarmed. Simplifying the procedures might enable Polish companies to use the transition period until 2008, during which they have to register their products according to EU rules. "Due to this while amending domestic pharmaceutical regulations, we should take all possible steps to introduce EPR before May 1, 2004," said Lewandowski. (Rzeczpospolita, p. B3) M.M.